Kpl Life Science Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 19-12-2024
- Paid Up Capital ₹ 1.07 M
as on 19-12-2024
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 31.89%
(FY 2022)
- Profit 26.53%
(FY 2022)
- Ebitda -344.06%
(FY 2022)
- Net Worth 11.63%
(FY 2022)
- Total Assets 6.32%
(FY 2022)
About Kpl Life Science
The Corporate was formerly known as Nucrone Lab Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.07 M, as per Ministry of Corporate Affairs (MCA) records.
Narayan Chaute, Kantibhai Chaute, and Laxman Chaute serve as directors at the Company.
- CIN/LLPIN
U24230GJ2006PTC047802
- Company No.
047802
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Feb 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Kpl Life Science Private Limited offer?
Kpl Life Science Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Gastrointestinal Drugs, Chemical Reagents & Catalysts, Inorganic Salts, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Nutritional Supplements, Antipyretic Medication, Paracetamol Tablets, Flavours & Aromatics.
Who are the key members and board of directors at Kpl Life Science?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narayan Chaute  | Director | 22-Oct-2008 | Current |
| Kantibhai Chaute | Director | 22-Oct-2008 | Current |
| Laxman Chaute | Director | 22-Oct-2008 | Current |
Financial Performance of Kpl Life Science.
Kpl Life Science Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 31.89% increase. The company also saw a substantial improvement in profitability, with a 26.53% increase in profit. The company's net worth Soared by an impressive increase of 11.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kpl Life Science?
In 2021, Kpl Life Science had a promoter holding of 27.96% and a public holding of 72.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chaute Textile Industries Private LimitedActive 31 years 6 monthsNarayan Chaute and Kantibhai Chaute are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kpl Life Science?
Unlock and access historical data on people associated with Kpl Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kpl Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kpl Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
